The PE Ratio as of November 2024 (TTM) for Celcuity Inc. (CELC) is -5.07

According to Celcuity Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -5.07. This represents a change of -21.27% compared to the average of -6.44 of the last 4 quarters.

Celcuity Inc. (CELC) Historical PE Ratio (quarterly & annually)

How has CELC PE Ratio performed in the past?

The mean historical PE Ratio of Celcuity Inc. over the last ten years is -18.47. The current -5.07 PE Ratio has changed 2.65% with respect to the historical average. Over the past ten years (40 quarters), CELC's PE Ratio was at its highest in in the June 2001 quarter at 0. The PE Ratio was at its lowest in in the March 2016 quarter at -1196.41.

Celcuity Inc. (CELC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Celcuity Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Celcuity Inc. (CELC) Average PE Ratio

How has CELC PE Ratio performed in the past?

The current PE Ratio of Celcuity Inc. (CELC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Celcuity Inc. (CELC) PE Ratio vs. Peers

How is CELC’s PE Ratio compared to its peers?

Celcuity Inc.’s PE Ratio is less than Werewolf Therapeutics, Inc. (-1.34), greater than Edgewise Therapeutics, Inc. (-24.30), less than Decibel Therapeutics, Inc. (-1.95), less than C4 Therapeutics, Inc. (-2.80), less than Anebulo Pharmaceuticals, Inc. (-4.78), less than Adagene Inc. (-3.02), less than Acrivon Therapeutics, Inc. Common Stock (-3.24), less than AnaptysBio, Inc. (-3.88), less than Mineralys Therapeutics, Inc. (-4.06), less than Molecular Partners AG (-2.50), less than MediciNova, Inc. (-0.04), greater than Champions Oncology, Inc. (-18.21), greater than Cyteir Therapeutics, Inc. (-9.12), less than Ikena Oncology, Inc. (-1.38), less than Rezolute, Inc. (-4.94), less than Aerovate Therapeutics, Inc. (-0.91), less than AN2 Therapeutics, Inc. (-0.66),

Build a custom stock screener for Celcuity Inc. (CELC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celcuity Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Celcuity Inc. (CELC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Celcuity Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.